Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms

Abstract

Sensitivity of tumor cells to anticancer therapy depends on the ability of the drug to induce apoptosis. However, multiple signaling pathways control this induction and thus determine this sensitivity. We report here that staurosporine, a well known inducer of apoptosis in a wide range of cell lines, displays distinct ability to trigger apoptosis in two different L1210 sublines (termed L1210/S and L1210/0). Staurosporine treatment resulted in an early cell death (within 3 h) in L1210/S cells, while in L1210/0 cells, death occurred only after 12 h. In both instances, death occurred by apoptosis. A broad spectrum caspase inhibitor, Z-VAD-fmk, blocked early apoptosis in L1210/S cells but did not confer any protection on late apoptosis in L1210/0 cells. Protection by Z-VAD-fmk observed in L1210/S cells was not lasting and unmasked a secondary process of cell death that also exhibited characteristics of apoptosis. Thus, staurosporine induces apoptotic cell death through at least two redundant parallel pathways. These two pathways normally coexist in L1210/S cells. However, the early cell death mechanism depending on caspase activation disguises the late caspase-independent apoptotic process. Staurosporine-induced apoptosis in L1210/0 cells develops only by the caspase-independent mechanism due to a general defect in caspase activation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Alnemri ES, Litwack G . 1990 J. Biol. Chem. 265: 17323–17333

  • Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuang J . 1996 Cell 87: 171

  • Bertrand R, Solary E, O'Connor P, Kohn KW, Pommier Y . 1994 Exp. Cell. Res. 211: 314–321

  • Brunet CL, Gunby RH, Benson RSP, Hickman JA, Watson AJM, Brady G . 1998 Cell Death Differ. 5: 107–115

  • Burchenal JH, Kalaher K, O'Toole T, Chilsholm J . 1977 Cancer Res. 37: 3455–3457

  • Coelho D, Holl V, Weltin D, Lacornerie T, Magneret P, Dufour P, Bishoff P . 2000 British J. Cancer 83: 642–649

  • Cohen GM . 1997 Biochem. J. 326: 1–16

  • Deas O, Dumont C, MacFarlane M, Rouleau M, Hebib C, Harper F, Hirsch F, Charpentier B, Cohen GM, Senik A . 1998 J. Immunol. 161: 3375–3383

  • Dive C, Hickman JA . 1991 Br. J. Cancer 64: 192–196

  • Eastman A, Bresnik E . 1981 Biochem. Pharm. 30: 2721–2723

  • Fernandes RS, Cotter TG . 1993 Anticancer Res. 13: 1253–1260

  • Fraser A, Evan G . 1996 Cell 85: 781–784

  • Hickman JA . 1992 Cancer Metastasis Rev. 11: 121–139

  • Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzani N, Marzo I, Geuskens M, Kroemer G . 1997 Oncogene 15: 1573–1581

  • Kim WJ, Mohan RR, Wilson SE . 2000 Exp. Eye Res. 71: 225–232

  • Kumar S, Lavin MF . 1996 Cell Death Diff. 3: 255–268

  • Lanotte M, Martin-Thouvenin Najman S, Ballerini P, Valensi F, Berger R . 1991 Blood 77: 1080–1086

  • Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GC . 1998 J. Cell Biol. 140: 637–645

  • Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC . 1994 Nature 371: 346–347

  • Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC . 1995 Proc. Natl. Acad. Sci. USA. 92: 9042–9046

  • Law L, Dunn T, Boyle P, Miller . 1949 J. Natl. Cancer Inst. 10: 179–192

  • Lemaire C, Andreau K, Souvannavong V, Adam A . 1998 FEBS Lett. 425: 266–270

  • Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM . 1997 Blood 90: 3118–3129

  • McCarthy NJ, Whyte MKB, Gilbert CS, Evan GI . 1997 J. Cell. Biol. 136: 215–227

  • McConkey DJ, Hartzell P, Amador-Perez J, Orrenius S, Jondal M . 1989 J. Immunol. 143: 1801–1806

  • Miller TM, Mouldner KL, Knudson CM, Creedon DJ, Desmukl M, Korsmeyer SJ, Johnson Jr EM . 1997 J. Cell Biol. 139: 205–217

  • Moore G, Sandberg A, Ulrich . 1966 J. Natl. Cancer Inst. 36: 405–421

  • Nicholson DW, Thornberry NA . 1997 Trends Biochem. Sci. 22: 299–306

  • Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK . 1995 Nature 276: 37–43

  • Orth K, O'Rourke K, Salvesen GS, Dixit VM . 1996 J. Biol. Chem. 271: 20977–20980

  • Sarré A-T, Bertrand R . 1999 Cancer Res. 59: 3565–3569

  • Ségal-Bendirdjian E, Jacquemin-Sablon A . 1995 Exp. Cell Res. 218: 201–212

  • Sen S, D'Incalci M . 1992 FEBS Lett. 307: 122–127

  • Tainton K, Ruefli AA, Smyth MJ, Johnstone RW . 2000 Biochem. Biophys. Res. Comm. 276: 231–237

  • Takahashi A, Alnemri E, Lazebnik Y, Fernades-Alnemri T, Litwack G, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, Earnshaw WC . 1996 Proc. Natl. Acad. Sci. USA. 93: 8395–8400

  • Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garci-Calvo M, Houtzager VM, Nordstram PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW . 1997 J. Biol. Chem. 272: 17907–17911

  • Trapani JA, Jans DA, Jans PJ, Smyth MJ, Browne KA, Sutton VR . 1998 J. Biol. Chem. 273: 27934–27938

  • Wolf BB, Green DR . 1999 Biol. Chem. 274: 20049–20052

  • Wyllie AH, Kerr JFR, Currie A . 1980 Int. Rev. Cytosol. 68: 251–306

  • Xiang J, Chao DT, Korsmeyer SJ . 1996 Proc. Natl. Acad. Sci. USA. 93: 14559–14563

Download references

Acknowledgements

We thank Dr A Eastman (Dartmouth, USA) and Dr S Cros (Toulouse, France) for generously providing the L1210/0 and L1210/S cell lines. We wish to aknowledge the assistance of Dr Macarena Robledo (INSERM EMI 003) who performed the flow cytometry analysis. Special acknowledgment is given to Dr M Lanotte (INSERM U496) for many helpful discussions and comments on this manuscript. This work was supported in part by grants from the Association pour la Recherche contre le Cancer (Villejuif, France) and from the Ligue Nationale contre le Cancer (Paris, France). CA Belmokhtar is supported by a Ligue Nationale contre le Cancer fellowship.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Belmokhtar, C., Hillion, J. & Ségal-Bendirdjian, E. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 20, 3354–3362 (2001). https://doi.org/10.1038/sj.onc.1204436

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204436

Keywords

This article is cited by

Search

Quick links